The plenary session at the ASCO 2022 annual meeting saw that rarest of things at a scientific conference: a standing ovation.
In modern oncology, important insights from clinical trials often emerge years after initial publication. As new therapies extend survival and transition more patients into long-term remissions, clinicians and researchers are increasingly looking beyond initial response rates to understand durability, long-term safety, and even the possibility of a cure.
